| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 46.586 | 109.037 | 162.763 | 265.939 | 296.092 | 577.872 | 838.809 |
| Total Income - EUR | - | - | 0 | 63.199 | 114.783 | 169.817 | 268.558 | 300.757 | 580.613 | 847.682 |
| Total Expenses - EUR | - | - | 4.519 | 42.739 | 95.570 | 158.105 | 227.494 | 98.193 | 331.630 | 501.764 |
| Gross Profit/Loss - EUR | - | - | -4.519 | 20.460 | 19.213 | 11.712 | 41.065 | 202.565 | 248.983 | 345.918 |
| Net Profit/Loss - EUR | - | - | -4.519 | 19.994 | 18.120 | 10.116 | 38.723 | 199.844 | 227.799 | 294.669 |
| Employees | - | - | 0 | 3 | 3 | 3 | 2 | 2 | 4 | 6 |
Check the financial reports for the company - Veroli Medax Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 26.438 | 24.255 | 27.136 | 86.230 | 79.144 | 103.740 | 166.406 |
| Current Assets | - | - | 188 | 30.449 | 37.594 | 47.327 | 28.915 | 151.284 | 445.458 | 193.035 |
| Inventories | - | - | 0 | 4.369 | 351 | 13.141 | 584 | 607 | 42.716 | 55.129 |
| Receivables | - | - | 0 | 1.962 | 99 | 263 | 306 | 145.140 | 136.381 | 10.828 |
| Cash | - | - | 188 | 24.117 | 37.143 | 33.922 | 28.025 | 5.538 | 266.361 | 86.870 |
| Shareholders Funds | - | - | -4.476 | 17.646 | 36.178 | 45.609 | 83.320 | 199.892 | 227.847 | 294.717 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 4.664 | 18.205 | 7.650 | 13.734 | 19.539 | 20.544 | 315.369 | 60.024 |
| Income in Advance | - | - | 0 | 21.035 | 18.021 | 15.121 | 12.285 | 9.992 | 7.669 | 5.139 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Veroli Medax Srl